A new study examines the strength, thermal response, microstructure, and cradle-to-site environmental impacts of pumice-based ...
Clare Bannon has been elected as the new chair of the BMA’s General Practitioners Committee for England (GPC England). Bannon, a GP in Barnsley and former deputy chair of GPC England, will succeed ...
Hero MotoCorp to invest Rs 3,200 cr in 3-5 yrs in Andhra Pradesh on capacity expansion, new global parts centre ...
MotoGP has banned the use of holeshot devices for the start of races with immediate effect, and will expand the space between rows on the grid to try to make race starts safer after a spate of violent ...
Bezzecchi was sensationally kicked out of the main race at Brno last Sunday, which – allied with Marc Marquez’s second win in succession where Bezzecchi scored zero points after crashing out of the ...
Barchart on MSN
O’Reilly Auto Parts stock skids 6.66% on little news. Its $85 share price is a gift for GARP investors
It was a good day in the markets on Monday, as all the major indexes were in positive territory: the S&P 500 was up 0.72%, ...
GSK has ended development of camlipixant in chronic cough after delivering mixed phase 3 data, dealing a major blow to a potential blockbuster that analysts saw as the key 2026 catalyst for the ...
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational ...
One trial, SIGMA, will evaluate Grifols’ intravenous immunoglobulin (Ig) GAMUNEX ® -C (immune globulin injection [human], 10% caprylate ...
GlobalData on MSN
First patients dosed in Grifols Phase III immunoglobulin trials
The SIGMA trial will assess Gamunex-C with standard medical treatment for patients with SID.
According to the GCL, its existing GPC residential modules deliver power outputs ranging from 475W to 500W, with efficiencies between 23.27% and 24.05%. Image: GCL-SI via PR Newswire. China-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results